Mohammad Doroudian

Dr. Mohammad Doroudian

Trinity College Dublin, Dublin, Ireland
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2022 in Cellular & Molecular Biology Letters
Verified
Journal Article
Open access
PDF file
AGAbdulwahab Teflischi Gharavi
Abdulwahab Teflischi Gharavi
NHNiloofar Asadi Hanjani
Niloofar Asadi Hanjani
EMElaheh Movahed
Elaheh Movahed
Mohammad DoroudianMohammad Doroudian
Mohammad Doroudian
Macrophages are influential members of the innate immune system that can be reversibly polarized by different microenvironment signals. Cell polarization leads to a wide range of features, involving the migration, development, and organization of the cells. There is mounting evidence that macrophage polarization plays a key role in the initiation and development of a wide range of diseases. This study aims to give an overview of macrophage polarization, their different subtypes, and the importance of alternatively activated M2 macrophage and classically activated M1 macrophage in immune responses and pathological conditions. This review provides insight on the role of exosomes in M1/M2-like macrophage polarization and their potential as a promising therapeutic candidate.

18 January 2016 in Medicinal Research Reviews
Verified
Journal Article
Closed access
PDF file
COCiaran O'Reilly
Ciaran O'Reilly
Mohammad DoroudianMohammad Doroudian
Mohammad Doroudian
LMLeona Mawhinney
Leona Mawhinney
SDSeamas C. Donnelly
Seamas C. Donnelly

1 January 2022 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
NHNiloofar Asadi Hanjani
Niloofar Asadi Hanjani
NENazanin Esmaelizad
Nazanin Esmaelizad
SZSaba Zanganeh
Saba Zanganeh
AGAbdulwahab Teflischi Gharavi
Abdulwahab Teflischi Gharavi
PHPegah Heidarizadeh
Pegah Heidarizadeh
Mohammad DoroudianMohammad Doroudian
Mohammad Doroudian

8 July 2019 in Thorax
Verified
Journal Article
Closed access
PDF file
Mohammad DoroudianMohammad Doroudian
Mohammad Doroudian
Ronan MacLoughlinRonan MacLoughlin
Ronan MacLoughlin
FPFergus Poynton
Fergus Poynton
APAdriele Prina-Mello
Adriele Prina-Mello
SDSeamas C. Donnelly
Seamas C. Donnelly
Nanomedicine is a multidisciplinary research field with an integration of traditional sciences such as chemistry, physics, biology and materials science. The application of nanomedicine for lung diseases as a relatively new area of interdisciplinary science has grown rapidly over the last 10 years. Promising research outcomes suggest that nanomedicine will revolutionise the practice of medicine, through the development of new approaches in therapeutic agent delivery, vaccine development and nanotechnology-based medical detections. Nano-based approaches in the diagnosis and treatment of lung diseases will, in the not too distant future, change the way we practise medicine. This review will focus on the current trends and developments in the clinical translation of nanomedicine for lung diseases, such as in the areas of lung cancer, cystic fibrosis, asthma, bacterial infections and COPD.

1 February 2021 in Current Opinion in Pharmacology
Verified
Journal Article
Open access
Mohammad DoroudianMohammad Doroudian
Mohammad Doroudian
ANAndrew O’ Neill
Andrew O’ Neill
Ronan MacLoughlinRonan MacLoughlin
Ronan MacLoughlin
APAdriele Prina-Mello
Adriele Prina-Mello
YVYuri Volkov
Yuri Volkov
SDSeamas C. Donnelly
Seamas C. Donnelly
Nanotechnology in medicine—nanomedicine—is extensively employed to diagnose, treat, and prevent pulmonary diseases. Over the last few years, this brave new world has made remarkable progress, offering opportunities to address historical clinical challenges in pulmonary diseases including multidrug resistance, adverse side effects of conventional therapeutic agents, novel imaging, and earlier disease detection. Nanomedicine is also being applied to tackle the new emerging infectious diseases, including severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), influenza A virus subtype H1N1 (A/H1N1), and more recently, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this review we provide both a historical overview of the application of nanomedicine to respiratory diseases and more recent cutting-edge approaches such as nanoparticle-mediated combination therapies, novel double-targeted nondrug delivery system for targeting, stimuli-responsive nanoparticles, and theranostic imaging in the diagnosis and treatment of pulmonary diseases.

22 September 2020 in Epigenomics
Verified
Journal Article
Closed access
JNJavid Sadri Nahand
Javid Sadri Nahand
NVNoushin Rezaei Vandchali
Noushin Rezaei Vandchali
HDHassan Darabi
Hassan Darabi
Mohammad DoroudianMohammad Doroudian
Mohammad Doroudian
HBHamid Reza Banafshe
Hamid Reza Banafshe
HMHamed Mirzaei
Hamed Mirzaei
Cervical cancer ranks fourth for both mortality and morbidity in women globally. Exosomes are considered as extracellular vesicles, secreted continuously by many cells with a size range from 30 to ...